5,7-Dihydroxyflavone Analogues May Regulate Lipopolysaccharide-Induced Inflammatory Responses by Suppressing IκBα-Linked Akt and ERK5 Phosphorylation in RAW 264.7 Macrophages

Author:

Nishina Atsuyoshi1ORCID,Shimizu Kazue1,Koketsu Mamoru2,Ninomiya Masayuki2,Sato Daisuke3,Suzuki Takashi4,Hayakawa Satoshi5,Kimura Hirokazu6ORCID

Affiliation:

1. College of Science and Technology, Nihon University, Chiyoda, Tokyo 101-0062, Japan

2. Department of Chemistry and Biomolecular Sciences, Faculty of Engineering, Gifu University, Gifu 501-1112, Japan

3. Department of Biomedical Information Engineering, Graduate School of Medical Science, Yamagata University, Yamagata 990-2332, Japan

4. School of Pharmacy, Nihon University, Funabashi, Chiba 274-8555, Japan

5. Nihon University School of Medicine, Itabashi, Tokyo 173-8610, Japan

6. National Institute of Infectious Diseases, Musashimurayama, Tokyo 208-0011, Japan

Abstract

We studied the anti-inflammatory activity of twelve 5,7-dihydroxyflavone analogues in lipopolysaccharide- (LPS-) stimulated RAW 264.7 macrophages. We found that chrysin (1) and 4′-methoxytricetin (9) showed relatively significant anti-inflammatory activity and low cytotoxicity. Moreover,1and9recovered the expression levels of iNOS and COX2, as well as those of the intracellular inflammatory mediators IL-1βand IL-6, which were upregulated by LPS stimulation. In addition,1and9actively regulated the phosphorylation of IκBα, leading to the activation of NFκB. Phosphorylation of Akt and ERK5 (upstream of NFκB) by LPS stimulation was significantly regulated by1and9, as well as by BIX 02189 and LY 294002, which are phosphorylation inhibitors of ERK5 and Akt, respectively. The results suggest that compounds1and9may suppress the levels of iNOS and COX2 by regulating phosphorylation of Akt, ERK5, and IκBαand thus NFκB-related signaling pathways, resulting in anti-inflammatory effects in the cells. Because1and9showed low cytotoxicity and regulated both PGE2and NO production caused by inflammatory responses, they may hold promise as natural anti-inflammatory agents.

Funder

Nihon University

Publisher

Hindawi Limited

Subject

Complementary and alternative medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3